Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. Of Cannassure.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 216

Cannabinoids Sleep Clinical Trials CBD 216

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

JULY 21, 2022

On July 1, the process of procuring pharmaceutical-approved cannabis was simplified for individuals residing across the state, where the first licensed medical marijuana dispensary opened its doors in August 2020. The latest changes to Virginia’s medical cannabis law adds to a growing list of amendments aimed at improving patient access.

Access 105

Access Dispensary Patients Programs 105

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Cannabis Law Report

JULY 28, 2021

On 1 June 2021, the Group announced an agreement with Voisin Consulting SARL (“VC”), a life sciences consultancy comprising over 200 professionals in the UK, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addictions.

Cannabinoids 81

Cannabinoids Clinical Trials Safety Medicine 81

Veriheal

JUNE 22, 2021

” The doorways opening to new cannabinoid research are monumental. Over the next decade, the United States could stand to see an explosion in the research of cannabinoid therapies. Go figure the federal government chose Mississippi to be the only state where researchers can access medical cannabis legally.

DEA 66

DEA Access Therapy Cannabinoids 66

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

MJ Business Attorneys

JUNE 29, 2018

DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Veriheal

AUGUST 13, 2020

In talking about cannabis and its uses, a lot of attention is always paid to THC, the most well known cannabinoid in the cannabis plant. CBD is a non-intoxicating cannabinoid that offers many of the same medical benefits as THC. Just a few months ago, Dr. Mechoulam discovered an all-new cannabinoid previously unknown to anyone.

Cannabinoids 98

Cannabinoids Chronic Pain Pharmaceutical Sleep 98

Cannabis Law Report

SEPTEMBER 22, 2021

Oxford Cannabinoid Technologies Holdings plc. . Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. As Canopy Growth remains focused on commercialisation, this agreement will grant OCT access to the Canopy Library to advance this research.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Our lead product, ANEB-001, has the potential to rapidly reverse the effects of acute cannabinoid intoxication, a relatively unknown yet serious affliction that sends more than 5,000 Americans to the hospital emergency department every day.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

Veriheal

SEPTEMBER 20, 2021

Now, the latest trend among folks living in states without access to legal cannabis is THC-O. While THC-O could be considered a cannabinoid, it’s better described as a compound due to being synthetically derived from hemp. Cannabinoid therapies and research have started to advance across the United States.

THC 98

THC Cannabinoids Vaping Hemp 98

Veriheal

OCTOBER 13, 2020

Ethan Russo theorized that IBS may present itself in an individual as a result of a deficiency in the body’s’ own cannabinoid chemicals, which are located in the endocannabinoid system (the ECS). Luckily, Dronabinol can be organically accessed in its botanical form, THC, directly from the plant. . Cannabis for GI Pathologies .

Digestion 124

Digestion Treatment Conditions Research and Development 124

Canna Care Docs

NOVEMBER 4, 2024

Common treatments for chronic pain can include: Pharmaceuticals (painkillers, anti-inflammatories) Physical therapy Lifestyle changes (exercise, diet) Despite medical advancements, many patients find these methods still don’t offer adequate relief. These cannabinoids work directly with the body’s endocannabinoid system (ECS).

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

Cannabis Law Report

OCTOBER 26, 2019

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 105

Sleep Cannabinoids Patients CBD 105

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

JUNE 17, 2021

NASDAQ: CLVR) said it has entered into an active pharmaceutical ingredient supply agreement with CBD Life Holding SAPI de CV, an emerging leader in the Mexican cannabis industry which offers a line of CBD Wellness and consumer products and medical cannabis products which are under development. Clever Leaves Holdings Inc.

CBD 85

CBD Pharmaceutical Media Compliance 85

LifeCannMD

JANUARY 31, 2025

Many people have tried everything countless pharmaceuticals and home remedies without finding relief from pain and inflammation, which are major symptoms of most autoimmune conditions. By activating the endocannabinoid system , cannabis can react with body in ways that typical pharmaceuticals cannot.

Conditions 97

Conditions Research and Development Treatment Patients 97

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Work with U.S. Mike Beyer.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Info

OCTOBER 4, 2019

The Scientist Who Identified THC Is Now Working on Synthetic Cannabinoids. Dr. Raphael Mechoulam , the scientist who first recognized the THC molecule in 1965, introduced his latest mission in California final week: constructing artificial cannabinoids. The plant produces a group of compounds called cannabinoid acids.

Cannabinoids 45

Cannabinoids THC Wellness and Beauty Research and Development 45

Veriheal

JANUARY 4, 2021

In adults with chronic pain, what are the harms of cannabinoids? In adults with chronic pain, what are the benefits of cannabinoids? Cannabis is a plant loaded with cannabinoids like THC , CBN , CBG , CBD , and others. Medicinal cannabinoid therapies are saving and changing lives for people across America and around the world.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Veriheal

DECEMBER 10, 2021

The Louisiana Department of Health recently notified businesses about an opportunity to obtain a license for making foods that contain cannabinoids. Consumable hemp is defined as “any product derived from industrial hemp that contains any cannabinoids and is intended for consumption or topical use.”

THC 98

THC Cannabinoids Hemp Chronic Pain 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. This system naturally produces cannabinoids in the bloodstream, but chronic stress, anxiety, and other stimuli can stifle the production of natural endocannabinoids.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Puff Puff Post

JUNE 5, 2019

As time started to pass by, the healing theories of marijuana plants were quickly replaced by those of big pharmaceutical companies. It wasn’t until the movement by thousands of patients and patient advocates in the 1990’s that propelled the government to allow fair access to medical marijuana. Legalization of recreational use.

Medicine 96

Medicine Patients Cannabinoids Oil 96

Cannabis Law Report

JULY 5, 2021

Bod also has a prescription product available to Australians – a pharmaceutical grade cannabidiol (CBD) based formulation called Medicabilis. Back in May, the company said it was launching a new product based on another cannabinoid – cannabigerol (CBG) – which will be sold under the MediCabilis brand as MediCabilis CBG 50 in the UK.

Cannabinoids 73

Cannabinoids CBD Pharmaceutical Access 73

Cannabis Law Report

MARCH 5, 2019

The PDF of the report can be accessed and downloaded at. Cannabis and cannabinoids for medical,scienti?c Pharmaceutical registration and prescription regimes . Medical uses of cannabinoids . ects of short-term medicinal cannabinoid use . Medical use of approved cannabinoids . Here’s the TOC.

Cannabinoids 66

Cannabinoids Pharmaceutical Compliance Compliance 66

Cannabis Law Report

JULY 26, 2021

VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co Ltd., ( CSE: CRFT ) (“ CRFT ” or the “ Company ”), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, is pleased to announce that its subsidiary, FeelWell Brands Inc. BC Craft Supply Co Ltd.

Events 105

Events Cannabinoids Advocacy Cannabis 105

Veriheal

SEPTEMBER 23, 2021

Despite growing evidence that cannabinoid therapies hold promise for treating many conditions, current federal laws and the stigma driving them continue to make it difficult for cannabis businesses to find affordable insurance plans. Current Insurance Options Are Costly and Limited.

Business 98

Business Access Cannabis Therapy 98

The Cannigma

JUNE 1, 2021

Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Unless someone is part of the exploratory initiative, the only way to gain access to cannabinoid medicines in France is to get a prescription for Sativex from a medical professional who specializes in multiple sclerosis.

Law 119

Law Epilepsy Programs Patients 119

The Cannigma

APRIL 12, 2023

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. Cannabis is often reported to help people reduce the number of pharmaceuticals they’re taking, and this trend continues in this study. While CBN is often marketed as “the sleep cannabinoid ,” the reality is more complicated.

Sleep 137

Sleep Data Tincture Research and Development 137

Cannabis Law Report

OCTOBER 27, 2021

a vertically integrated provider of safe and sustainable specialty ingredients, today announced that it has successfully completed commercial-scale, fermentation-based production campaigns for its Lygos CBx cannabinoid products, including CBG (cannabigerol), CBC (cannabichromene), CBD (cannabidiol), and CBDA (cannabidiolic acid).

Cannabinoids 40

Cannabinoids Pharmaceutical Agriculture CBD 40